Rehman, E. et al. (2022) “High Risk of Cardiovascular Events in Patients, Biosynthesis of Aspirin-Resistant Thromboxane And The Risk Of Stroke, Myocardial Infarction Or Death: Biosynthesis of Aspirin-Resistant Thromboxane & Risk of Stroke”, Pakistan BioMedical Journal, 5(6), pp. 213–218. doi:10.54393/pbmj.v5i6.583.